Casdin Capital, LLC
Filing Date
Global Rank
#1,273
/ 8,232
▲ 361
Top Industry
Biotechnology
53.4%
3Y Alpha vs SPY
-9.9%
Period ended 2 months ago
Filed May 15, 2026 · 30d
24 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+36.5%
SPY
+76.3%
Annualised alpha
-9.9%
Max drawdown
−39.3%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
40 positions · as of Mar 31, 2026 · Δ vs Sep 30, 2025Top Position
19.0%
−9.9 pts
Top 5
59.3%
−10.2 pts
Top 10
77.3%
−8.3 pts
HHI
903
Diversified−468
Portfolio Trend
24 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $1,320,653,767 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
9 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| LAB | Standard Biotools Inc. | +11,225,000 | 88,783,856 | $81,681,147 | |
| RLAY | Relay Therapeutics, Inc. | +3,077,193 | 14,418,574 | $143,464,811 | |
| DNLI | Denali Therapeutics Inc. | +950,000 | 1,840,000 | $35,328,000 | |
| HIMS | Hims & Hers Health, Inc. | +470,000 | 700,000 | $14,532,000 | |
| GH | Guardant Health, Inc. | +215,000 | 315,000 | $29,096,550 | |
| NGNE | Neurogene Inc. | +125,000 | 1,420,361 | $28,634,477 | |
| GLUE | Monte Rosa Therapeutics, Inc. | +100,000 | 186,014 | $3,059,930 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | +20,000 | 75,000 | $24,815,250 | |
| ILMN | Illumina, Inc. | +5,000 | 530,000 | $65,327,800 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
4 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| BLFS | Biolife Solutions Inc | −750,000 | 5,957,165 | $113,662,708 | |
| GPCR | Structure Therapeutics Inc. | −380,000 | 1,175,000 | $56,635,000 | |
| BEAM | Beam Therapeutics Inc. | −250,000 | 1,350,000 | $32,170,500 | |
| RVMD | Revolution Medicines, Inc. | −70,000 | 2,577,333 | $250,645,634 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
13 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| TXG | 10x Genomics, Inc. | 2,275,000 | $48,298,250 | |
| SRRK | Scholar Rock Holding Corp | 350,000 | $17,206,000 | |
| AGMB | Agomab Therapeutics NV | 1,550,000 | $16,259,500 | |
| TSHA | Taysha Gene Therapies, Inc. | 3,250,000 | $14,527,500 | |
| QGEN | Qiagen N.V. | 360,000 | $14,414,400 | |
| GRAL | GRAIL, Inc. | 230,000 | $11,886,400 | |
| PSNL | Personalis, Inc. | 1,600,000 | $10,192,000 | |
| DGX | Quest Diagnostics Inc | 50,000 | $9,799,000 | |
| MLTX | MoonLake Immunotherapeutics | 450,000 | $8,388,000 | |
| NTLA | Intellia Therapeutics, Inc. | 355,000 | $4,551,100 | |
| IRON | Disc Medicine, Inc. | 65,000 | $4,156,100 | |
| MRNA | Moderna, Inc. | 75,000 | $3,810,000 | |
| ANL | Adlai Nortye Ltd. | 538,461 | $3,726,150 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
4 positions
40 positions ·
$1,320,653,767 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 2,577,333 | $250,645,634 | 18.98% | |
| WGS |
GeneDx Holdings Corp.
Healthcare
|
Held | 3,007,164 | $193,120,072 | 14.62% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Added | 14,418,574 | $143,464,811 | 10.86% | |
| BLFS |
Biolife Solutions Inc
Healthcare
|
Reduced | 5,957,165 | $113,662,708 | 8.61% | |
| LAB |
Standard Biotools Inc.
Healthcare
|
Added | 88,783,856 | $81,681,147 | 6.18% | |
| ILMN |
Illumina, Inc.
Healthcare
|
Added | 530,000 | $65,327,800 | 4.95% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Reduced | 1,175,000 | $56,635,000 | 4.29% | |
| TXG |
10x Genomics, Inc.
Healthcare
|
NEW | 2,275,000 | $48,298,250 | 3.66% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
Added | 1,840,000 | $35,328,000 | 2.68% | |
| BEAM |
Beam Therapeutics Inc.
Healthcare
|
Reduced | 1,350,000 | $32,170,500 | 2.44% | |
| GH |
Guardant Health, Inc.
Healthcare
|
Added | 315,000 | $29,096,550 | 2.20% | |
| NGNE |
Neurogene Inc.
Healthcare
|
Added | 1,420,361 | $28,634,477 | 2.17% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
Added | 75,000 | $24,815,250 | 1.88% | |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
Held | 758,857 | $22,651,881 | 1.72% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
NEW | 350,000 | $17,206,000 | 1.30% | |
| AGMB |
Agomab Therapeutics NV
Healthcare
|
NEW | 1,550,000 | $16,259,500 | 1.23% | |
| HIMS |
Hims & Hers Health, Inc.
Healthcare
|
Added | 700,000 | $14,532,000 | 1.10% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
NEW | 3,250,000 | $14,527,500 | 1.10% | |
| QGEN |
Qiagen N.V.
Healthcare
|
NEW | 360,000 | $14,414,400 | 1.09% | |
| TEM |
Tempus AI, Inc.
Healthcare
|
Held | 294,127 | $13,300,422 | 1.01% | |
| SEPN |
Septerna, Inc.
Healthcare
|
Held | 553,268 | $13,295,030 | 1.01% | |
| GRAL |
GRAIL, Inc.
Healthcare
|
NEW | 230,000 | $11,886,400 | 0.90% | |
| PRME |
Prime Medicine, Inc.
Healthcare
|
Held | 3,167,175 | $11,021,769 | 0.83% | |
| PSNL |
Personalis, Inc.
Healthcare
|
NEW | 1,600,000 | $10,192,000 | 0.77% | |
| DGX |
Quest Diagnostics Inc
Healthcare
|
NEW | 50,000 | $9,799,000 | 0.74% | |
| VCYT |
Veracyte, Inc.
Healthcare
|
Held | 276,308 | $8,899,880 | 0.67% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
NEW | 450,000 | $8,388,000 | 0.64% | |
| NTLA |
Intellia Therapeutics, Inc.
Healthcare
|
NEW | 355,000 | $4,551,100 | 0.34% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
NEW | 65,000 | $4,156,100 | 0.31% | |
| MRNA |
Moderna, Inc.
Healthcare
|
NEW | 75,000 | $3,810,000 | 0.29% | |
| ANL |
Adlai Nortye Ltd.
Healthcare
|
NEW | 538,461 | $3,726,150 | 0.28% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Added | 186,014 | $3,059,930 | 0.23% | |
| ABSI |
Absci Corp
Healthcare
|
Held | 973,260 | $2,919,780 | 0.22% | |
| IPSC |
Century Therapeutics, Inc.
Healthcare
|
Held | 1,228,190 | $2,775,709 | 0.21% | |
| BBOT |
BridgeBio Oncology Therapeutics, Inc.
Healthcare
|
Held | 282,312 | $2,526,692 | 0.19% | |
| CTNM |
Contineum Therapeutics, Inc.
Healthcare
|
Held | 148,333 | $1,937,228 | 0.15% | |
| PACB |
Pacific Biosciences Of California, Inc.
Healthcare
|
Held | 723,767 | $955,372 | 0.07% | |
| RXRX |
Recursion Pharmaceuticals, Inc.
Healthcare
|
Held | 165,323 | $507,541 | 0.04% | |
| TNYA |
Tenaya Therapeutics, Inc.
Healthcare
|
Held | 361,969 | $250,482 | 0.02% | |
| DNA |
Ginkgo Bioworks Holdings, Inc.
Healthcare
|
Held | 36,493 | $223,702 | 0.02% |